@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:approve . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:11.012574"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" . rdf:OBJECT-POSITION rdfs:label "(0, 8)" . rdf:PREDICATE rdfs:label "approved" . rdf:PREDICATE-POSITION rdfs:label "112" . rdf:SUBJECT rdfs:label "Steroids ( Methylprednisolone or Dexamethasone ) and Tocilizumab ( TCZ ) , an interleukin-6 receptor antagonist" . rdf:SUBJECT-POSITION rdfs:label "(0, 8)" . rdf:Statement rdfs:label "Steroids (Methylprednisolone or Dexamethasone) and Tocilizumab (TCZ), an interleukin-6 receptor antagonist, are approved for the treatment of Cytokine release syndrome (CRS) or cytokine storm in India." . rdfs:ABSTRACT-UID ns2:50 "9wycjlj5" . rdfs:TRIPLE-UID ns1:9wycjlj5-TRIPLE-ABSTRACT-1 "9wycjlj5-TRIPLE-ABSTRACT-1" . rdfs:label "cytokine release syndrome" . rdfs:label "steroids" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }